Data as of Dec 10
| +0.03 / +0.05%|
The 30 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 51.93, with a high estimate of 61.81 and a low estimate of 41.59. The median estimate represents a -8.51% decrease from the last price of 56.76.
The current consensus among 32 polled investment analysts is to Hold stock in AstraZeneca PLC. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.